Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3784
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03662126 | KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment | ||
| NCT00845299 | Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma | ||
| NCT00911287 | Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain | ||
| NCT00266214 | Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome | ||
| NCT04341948 | Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System | ||
| NCT07516093 | Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL | ||
| NCT04149821 | Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy | ||
| NCT04681248 | Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors | ||
| NCT06384547 | A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) | ||
| NCT01495364 | NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction | ||
| NCT04240314 | AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications. | ||
| NCT00522652 | Phase I Trial of PX-478 | ||
| NCT06598371 | A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors | ||
| NCT05838833 | Ointment to Prevent Scar After Thyroidectomy | ||
| NCT03394755 | Thrombosomes® in Bleeding Thrombocytopenic Patients | ||
| NCT03675126 | An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen) | ||
| NCT02575404 | GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients | ||
| NCT02516904 | A Single Ascending Dose Study of CD101 IV in Healthy Subjects | ||
| NCT06990984 | A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) | ||
| NCT04202965 | PTG-300 in Subjects With Hereditary Hemochromatosis | ||
| NCT05980949 | Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) | ||
| NCT06941844 | A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) | ||
| NCT02805660 | Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC | ||
| NCT05313386 | Study of BXCL501 In Agitation Associated With Delirium in ICU Patients | ||
| NCT02343042 | Selinexor and Backbone Treatments of Multiple Myeloma Patients | ||
| NCT04432155 | Xenon Inhalation for Treatment of Panic Disorder | ||
| NCT05255276 | PK Study to Assess Drug-drug Interaction Between Sitravatinib and a P-gp Inducer and an Inhibitor. | ||
| NCT07024589 | First-in-Human Trial of Oral AN2-502998 | ||
| NCT02978859 | Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas | ||
| NCT01649388 | A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients | ||
| NCT02336815 | Selinexor Treatment of Refractory Myeloma | ||
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | ||
| NCT05438160 | Exploratory Study of a Digital Therapeutics in People With Schizophrenia | ||
| NCT07389590 | Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis | ||
| NCT06825559 | Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease | ||
| NCT03340883 | Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) | ||
| NCT02138786 | Selinexor in Initial or Refractory and/or Relapsed Richter's Transformation | ||
| NCT03250182 | A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose | ||
| NCT04849273 | A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC | ||
| NCT07323654 | A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma | ||
| NCT02656303 | A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304 | ||
| NCT07564154 | A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA) | ||
| NCT06093451 | Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder | ||
| NCT03609619 | PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations | ||
| NCT05004675 | Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients | ||
| NCT05166577 | Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC | ||
| NCT04485260 | An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib | ||
| NCT04732520 | Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer | ||
| NCT01168713 | Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia | ||
| NCT04421820 | BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours |
